共 50 条
- [2] Risks to the 340B Drug Pricing Program Related to Manufacturer Restrictions on Drug Availability JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (17): : 1647 - 1648
- [3] Consequences of the 340B Drug Pricing Program NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (06): : 539 - 548
- [4] 340B Drug Pricing Program and Hospital Provision of Uncompensated Care AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (10): : 432 - +
- [5] Risks to the 340B Drug Pricing Program JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (11): : 1109 - 1109
- [9] HIV Prevention and the 340B Drug Pricing Program NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06): : 575 - 576
- [10] Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior? BMC Research Notes, 14